All Stories

  1. Antiviral Activity of Trappin-2 and Elafin In Vitro and In Vivo against Genital Herpes

    Article • Journal of Virology, May 2013, ASM Journals

    Ken Rosenthal

  2. Anti-HIV-1 Activity of Elafin Depends on Its Nuclear Localization and Altered Innate Immune Activation in Female Genital Epithelial Cells

    Article • PLoS ONE, December 2012, PLOS

    Ken Rosenthal

  3. Milk Matters: Soluble Toll-Like Receptor 2 (sTLR2) in Breast Milk Significantly Inhibits HIV-1 Infection and Inflammation

    Article • PLoS ONE, July 2012, PLOS

    Ken Rosenthal

  4. Trappin-2/Elafin Modulate Innate Immune Responses of Human Endometrial Epithelial Cells to PolyI∶C

    Article • PLoS ONE, April 2012, PLOS

    Ken Rosenthal

  5. Anti-HIV-1 Activity of Elafin Is More Potent than Its Precursor's, Trappin-2, in Genital Epithelial Cells

    Article • Journal of Virology, February 2012, ASM Journals

    Ken Rosenthal

  6. War and peace between WAP and HIV: role of SLPI, trappin-2, elafin and ps20 in susceptibility to HIV infection

    Article • Biochemical Society Transactions, October 2011, Portland Press Ltd.

    Ken Rosenthal

  7. Intravaginal infection with herpes simplex virus type-2 (HSV-2) generates a functional effector memory T cell population that persists in the murine genital tract

    Article • Journal of Reproductive Immunology, December 2010, Elsevier

    Ken Rosenthal

  8. Multiple tandem copies of conserved gp41 epitopes incorporated in gag virus-like particles elicit systemic and mucosal antibodies in an optimized heterologous vector delivery regimen

    Article • Vaccine, October 2010, Elsevier

    Ken Rosenthal

  9. Development of Functional Human NK Cells in an Immunodeficient Mouse Model with the Ability to Provide Protection against Tumor Challenge

    Article • PLoS ONE, December 2009, PLOS

    Ken Rosenthal

  10. Mucosal Innate and Adaptive Immune Responses against Herpes Simplex Virus Type 2 in a Humanized Mouse Model

    Article • Journal of Virology, August 2009, ASM Journals

    Ken Rosenthal

  11. HIV-1 RNA Dysregulates the Natural TLR Response to Subclinical Endotoxemia in Kenyan Female Sex-Workers

    Article • PLoS ONE, May 2009, PLOS

    Ken Rosenthal

  12. Differential induction of innate anti-viral responses by TLR ligands against Herpes simplex virus, type 2, infection in primary genital epithelium of women

    Article • Antiviral Research, February 2009, Elsevier

    Ken Rosenthal

  13. Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infection

    Article • AIDS, March 2008, Wolters Kluwer Health

    Ken Rosenthal

  14. Expression of Toll-like receptors in murine vaginal epithelium is affected by the estrous cycle and stromal cells

    Article • Journal of Reproductive Immunology, October 2007, Elsevier

    Ken Rosenthal

  15. NK and NKT Cell-Independent Contribution of Interleukin-15 to Innate Protection against Mucosal Viral Infection

    Article • Journal of Virology, April 2005, ASM Journals

    Ken Rosenthal

  16. Recombinant Live Viral Vectors as Vaccines for Mucosal Immunity

    Article • January 2005, Elsevier

    Ken Rosenthal

  17. Toll‐Like Receptor (TLR)–3, but Not TLR4, Agonist Protects against Genital Herpes Infection in the Absence of Inflammation Seen with CpG DNA

    Article • The Journal of Infectious Diseases, November 2004, Oxford University Press (OUP)

    Ken Rosenthal

  18. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2

    Article • Vaccine, August 2004, Elsevier

    Ken Rosenthal

  19. Parameters of CpG oligodeoxynucleotide‐induced protection against intravaginal HSV‐2 challenge

    Article • Journal of Medical Virology, October 2003, Wiley

    Ken Rosenthal

  20. Interleukin-15 and Natural Killer and NKT Cells Play a Critical Role in Innate Protection against Genital Herpes Simplex Virus Type 2 Infection

    Article • Journal of Virology, September 2003, ASM Journals

    Ken Rosenthal

  21. Progesterone Increases Susceptibility and Decreases Immune Responses to Genital Herpes Infection

    Article • Journal of Virology, April 2003, ASM Journals

    Ken Rosenthal

  22. Toll-like Receptor 9, CpG DNA and Innate Immunity

    Article • Current Molecular Medicine, September 2002, Bentham Science Publishers

    Ken Rosenthal

  23. HIV‐1‐specific cellular immune responses among HIV‐1‐resistant sex workers

    Article • Immunology and Cell Biology, December 2000, Wiley

    Ken Rosenthal

  24. Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners

    Article • The Journal of Infectious Diseases, July 2000, Oxford University Press (OUP)

    Ken Rosenthal

  25. Cytotoxic T-lymphocytes from HIV-infected individuals recognize an activation-dependent, non-polymorphic molecule on uninfected CD4+ lymphocytes

    Article • AIDS, March 1996, Wolters Kluwer Health

    Ken Rosenthal

  26. Non-MHC-restricted T lymphocytes and immune regulation

    Article • Clinical Immunology Newsletter, January 1994, Elsevier

    Ken Rosenthal

  27. Changes in the Cytotoxic T-Cell Repertoire of HIV-1-Infected Individuals: Relationship to Disease Progression

    Article • Viral Immunology, January 1993, Mary Ann Liebert Inc

    Ken Rosenthal

  28. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects

    Article • AIDS, October 1992, Wolters Kluwer Health

    Ken Rosenthal